We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Instead of donor T cell depletion, we used CTLA4 and TJU103 (a small organic compound believed to block CD4 binding to MHC II molecule of APC) to block donor T lymphocyte activation in vitro before(More)
  • 1